Tuesday, September 13, 2016

BRIEF-Ligand says initiates phase 2 trial with LGD-6972

* Says multiple site study is expected to enroll 148

subjects with T2DM

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)